Predicted incidence of oral cavity, oropharyngeal, laryngeal, and hypopharyngeal cancer in Spain and implications for cancer control

Cancer Epidemiology

Volumn 35, Issue 6, 2011, Pages 510-514

  de Souza, Dyego Leandro Bezerra ^a   Bernal Pérez, María Milagros ^a   Curado, Maria Paula ^b  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Head and neck cancers; Incidence; Predictions; Spain; Trends

Indexed keywords

ALCOHOL;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; DEMOGRAPHY; FEMALE; HUMAN; HYPOPHARYNX CANCER; INFANT; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MODEL; MOUTH CANCER; NEWBORN; OROPHARYNX CANCER; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK REDUCTION; SCHOOL CHILD; SEX DIFFERENCE; SPAIN; TOBACCO;

ADULT; AGE DISTRIBUTION; FEMALE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; INCIDENCE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS; SPAIN; YOUNG ADULT;

EID: 81055129361     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2011.02.012     Document Type: Article

References (32)

1. Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M., et al. Cancer incidence in five continents 2008, IARC Scientific Publications, Lyon, France. M.P. Curado, B. Edwards, H.R. Shin (Eds.).
2. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46(4 MARCH):765-781.
3. Olsen A.H., Parkin D.M., Sasieni P. Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer 2008, 99(9NAVEMBER):1549-1554.
4. Bray F., Moller B. Predicting the future burden of cancer. Nat Rev Cancer 2006, 6(1 JANUARY):63-74.
5. Domenech A.C., Pérez-Gómez B., Aragonés N., Pollán M., López-Abente G. La situación del cáncer en españa, 1975-2006 2009, Centro Nacional de Epidemiologia, Instituto Carlos III, Madrid, España.
6. de Camargo Cancela M., Voti L., Guerra-Yi M., Chapuis F., Mazuir M., Curado M.P. Oral cavity cancer in developed and in developing countries: population-based incidence. Head Neck 2010, 32(3 MARCH):357-367.
7. Hashibe M., Brennan P., Chuang S.C., Boccia S., Castellsague X., Chen C., et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2009, 18(2 FEBRUARY):541-550.
8. Chaturvedi A.K., Engels E.A., Anderson W.F., Gillison M.L. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008, 26(4 FEBRUARY):612-619.
9. Ferlay J., Parkin D.M., Curado M.P., Bray F., Edwards B., Shin H.R., et al. Cancer incidence in five continents: IARC CancerBase no. 9 [internet] 2010, vols. I-IX. International Agency for Research on Cancer, Lyon, France.
10. Fritz A., Percy C., Jack A., Shanmugaratnam K., Sobin L., Parkin D.M., et al. International classification of diseases for oncology, ICD-O 2000, World Health Organization, Geneva. A. Fritz, C. Percy, A. Jack (Eds.).
11. Moller B., Fekjaer H., Hakulinen T., Tryggvadottir L., Storm H.H., Talback M., et al. Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 2002, 11(SUPPL. 1 JUNE):S1-S96.
12. Moller B., Fekjaer H., Hakulinen T., Sigvaldason H., Storm H.H., Talback M., et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med 2003, 22(17 (SEPTEMBER:2751-2766.
13. Instituto nacional de estadística (INE) [internet]. Available from: http://www.ine.es/.
14. Instituto nacional de estadística (INE) [internet]. Available from: http://www.ine.es/en/prensa/np587_en.pdf.
15. Navarro C., Martos C., Ardanaz E., Galceran J., Izarzugaza I., Peris-Bonet R., et al. Population-based cancer registries in Spain and their role in cancer control. Ann Oncol 2010, 21(SUPPL. 3 MAY):iii3-iii13.
16. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2 MARCH-APRIL):74-108.
17. GLOBOCAN Cancer incidence and mortality worldwide: IARC CancerBase no. 10 [internet] 2008, International Agency for Research on Cancer, Lyon, France, Available from: http://globocan.iarc.fr.
18. Encuesta nacional de salud - españa; 1987, 1993, 1995, 1997 y 2001 [internet]. Available from: http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/home.htm.
19. Borras J., Borras J.M., Galceran J., Sanchez V., Moreno V., Gonzalez J.R. Trends in smoking-related cancer incidence in Tarragona, Spain, 1980-96. Cancer Causes Control 2001, 12(10 DECEMBER):903-908.
20. Bernal M., Gómez G., Gómez F. Incremento notable del cáncer de pulmón en mujeres españolas desde el año 2000. Oncología 2005, 28(6):282-287.
21. Shafey O., Eriksen M., Ross H., Mackay J. El atlas del tabaco 2009, American Cancer Society, Atlanta, USA.
22. Bejar L., Gili M., Lopez J., Ramirez G., Cabanillas J., Cruz C. Trends in colorectal cancer in Spain from 1951-2007 and alcohol and cigarette consumption. Gastroenterol Hepatol 2010, 33(2 FEBRUARY):71-79.
23. Encuesta nacional de salud - españa; 2006 [internet]. Available from: http://www.msc.es/estadEstudios/estadisticas/encuestaNacional/home.htm.
24. Auluck A., Hislop G., Bajdik C., Poh C., Zhang L., Rosin M. Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer 2010, MARCH.
25. D'Souza G., Agrawal Y., Halpern J., Bodison S., Gillison M.L. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009, 199(9 MAY):1263-1269.
26. Ragin C.C., Modugno F., Gollin S.M. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007, 86(2 FEBRUARY):104-114.
27. Gillison M.L. Human papillomavirus-related diseases: oropharynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health 2008, 43(4 SUPPL. OCTOBER):S52-S60.
28. Liu P.H., Hu F.C., Lee P.I., Chow S.N., Huang C.W., Wang J.D. Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan. BMC Health Serv Res 2010, 10 JANUARY:11.
29. Syrjanen K.J. Prophylactic HPV vaccines: the Finnish perspective. Expert Rev Vaccines 2010, 9(1 JANUARY):45-57.
30. Bastos J., Peleteiro B., Gouveia J., Coleman M.P., Lunet N. The state of the art of cancer control in 30 European countries in 2008. Int J Cancer 2010, 126(11 JUNE):2700-2715.
31. Palefsky J.M. Human papillomavirus-related disease in men: not just a women's issue. J Adolesc Health 2010, 46(4 SUPPL. ARRIL):S12-S19.
32. Cortes-Bordoy J., Martinon-Torres F. The Spanish human papillomavirus vaccine consensus group: a working model. Hum Vaccin 2010, 6(9 (SEPTEMBER.